Shannon John Patrick Jr Insider Trading Activity

Average Profitability
19.99%
Insider Buys Quantity
6
Insider Buys Sum
$566,325.68
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Shannon John Patrick Jr

According to the SEC Form 4 filings, Shannon John Patrick Jr, being in a position of

  1. See Remarks at Xeris Biopharma Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 48149 shares for $349,658,
    over all time since 2020-02-14, has bought 214637 shares for $566,326, and sold 48149 shares for $349,658.

Biography of Shannon John Patrick Jr

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $349,6582100

Comparison of Insiders on Amount of Buys and Sells

2026-01-05SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
24,907
0.015%
$7.08$176,257+4.37%
2025-11-13SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
23,242
0.0144%
$7.46$173,402-0.69%
2023-11-17PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
30,769
0.0206%
$1.64$50,400+34.46%
2021-11-12PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
60,000
0.0484%
$2.10$126,000-2.8%
2021-11-11PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
40,000
0.033%
$2.09$83,5000%
2020-05-13PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
44,000
0.1135%
$3.55$155,989+29.7%
2020-05-08PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
15,772
0.0411%
$3.20$50,439+45.82%
2020-02-14PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
24,096
0.0762%
$4.15$99,998+12.75%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.